Benzinga | Aug 10, 2020 04:14PM EDT

Cormedix Q2 EPS $(0.14), Inline, Sales $16.44M Up From $35.27K YoY

Cormedix (AMEX:CRMD) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 366.67 percent decrease over losses of $(0.03) per share from the same period last year. The company reported $16.44 million in sales this quarter. This is a 46.53K percent increase over sales of $35.27 thousand the same period last year.